Trials / Conditions / Recurrent T-Cell Non-Hodgkin Lymphoma

Recurrent T-Cell Non-Hodgkin Lymphoma

13 registered clinical trials studyying Recurrent T-Cell Non-Hodgkin Lymphoma — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treat NCT07225985	Fred Hutchinson Cancer Center	Phase 1 / Phase 2
Active Not Recruiting	Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have R NCT05627245	National Cancer Institute (NCI)	Phase 1
Withdrawn	Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed A NCT04220008	M.D. Anderson Cancer Center	Phase 2
Completed	Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem NCT03259503	M.D. Anderson Cancer Center	Phase 1
Completed	Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymp NCT03409432	John Reneau	Phase 2
Completed	Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin NCT03210662	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractor NCT02978625	National Cancer Institute (NCI)	Phase 2
Completed	Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma NCT03035331	Mayo Clinic	Phase 1 / Phase 2
Recruiting	A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemi NCT03017820	Mayo Clinic	Phase 1
Completed	Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients NCT01921387	Fred Hutchinson Cancer Center	Phase 1 / Phase 2
Completed	Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin NCT01076543	National Cancer Institute (NCI)	Phase 1 / Phase 2
Terminated	Iodine I 131 Monoclonal Antibody BC8 Before Autologous Stem Cell Transplant in Treating Patients With Relapsed NCT00860171	Fred Hutchinson Cancer Center	Phase 1
Completed	Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer NCT00723099	Fred Hutchinson Cancer Center	Phase 2